AZN vs CBZ · P/E 28, $288.38B cap vs P/E 63, rev $1.53B
AstraZeneca PLC (AZN) versus CBIZ Inc (CBZ) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
CBIZ Inc (CBZ) is a specialty business services company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported CBZ revenue for 2026-06-30 was $1.53B. Net income was $171.4M. Revenue was up 120.6% from 2025-09-30 to 2026-06-30. CBZ currently screens at market cap $3.98B and trailing P/E 63.1.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. CBZ currently screens at market cap $3.98B and trailing P/E 63.1.
Not investment advice. Open the AZN and CBZ stock pages for the full models.
Not investment advice.